Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Piqray 200mg


Contraindicated
Foetotoxicity

Contraindicated
Piqray 200mg :
Type Medicine Authorised
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01XX65

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 01/05/2019

Revision Date : 01/05/2019

Piqray 200mg  MoH 11014 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 28
Strength 200mg
Storage Condition <30°C protect from humidity & light
Public Price 5891688 L.L.
Stratum E2
NSSF
Quarantine
Reg. Number 32921/1
Submission date 2021
Registration Year 01/02/2023




NB : Reregistration in 2023 with same manufacturer


Price Comparison

Country: Qatar
Package Size: 28's
Public Price: 30222 QAR ( 742,191,876.00 LBP )
Pack size unit used: 28
Cost/Unit: 1079,3571 QAR ( 26,498,082.00 LBP )
Pharmacy Price: 24824.8338 QAR ( 609648268.4604 LBP )
Pricing Date: 28/01/2021
Type: Medicine Authorised

Country: Oman
Package Size: 4x7
Public Price: 3182.03 OMR ( 734,202,510.02 LBP )
Pack size unit used: 28
Cost/Unit: 113,6439 OMR ( 26,072,942.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 28s
Public Price: 28240.5 AED ( 682,318,720.50 LBP )
Pack size unit used: 28
Cost/Unit: 1008,5893 AED ( 24,354,288.00 LBP )
Pharmacy Price: 24056.8 AED ( 581236344.8 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: Switzerland
Package Size: 28
Public Price: 4514.35 CHF ( 466,874,077.00 LBP )
Pack size unit used: 28
Cost/Unit: 161,2268 CHF ( 16,650,620.00 LBP )
Exfactory Price: 4164.24 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: UK
Package Size: 28
Public Price: 4082.14 GBP ( 463,931,128.86 LBP )
Pack size unit used: 28
Cost/Unit: 145,7907 GBP ( 16,479,105.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Denmark
Package Size: 28 stk
Public Price: 34121.9 DKK ( 442,765,774.40 LBP )
Pack size unit used: 28
Cost/Unit: 1218,6393 DKK ( 15,804,768.00 LBP )
Pharmacy Price: 25364.35 DKK ( 329127805.6 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: KSA
Package Size: 28
Public Price: 17606.34 SAR ( 416,213,877.60 LBP )
Pack size unit used: 28
Cost/Unit: 628,7979 SAR ( 14,845,920.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: The Netherlands
Package Size: 28
Public Price: 3930.92 EUR ( 380,811,805.92 LBP )
Pack size unit used: 28
Cost/Unit: 140,39 EUR ( 13,562,640.00 LBP )
Pharmacy Price: 3923.92 EUR ( 380133673.92 LBP )
Reference: Zorginstituut Nederland
Pricing Date: 23/03/2021
Type: Medicine Authorised

Country: Greece
Package Size: 28
Public Price: 3515.46 EUR ( 340,563,702.96 LBP )
Pack size unit used: 28
Cost/Unit: 125,5521 EUR ( 12,109,500.00 LBP )
Exfactory Price: 3203.385 EUR
Pharmacy Price: 3251.44 EUR ( 314986501.44 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/02/2021

Country: Lebanon
Form: Tablet, Film-Coated
Package Size: Box of 28
Public Price: 5891688 LBP ( 5,891,688.00 LBP )
Pack size unit used: 28
Cost/Unit: 210417,43 LBP ( 210,417.00 LBP )
Pricing Date: 13/06/2024

Country: France
Package Size: 28
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 1079,3571 QAR ( 26,498,082.00 LBP )
Cost/Day: 1079,36 QAR ( 26,498,082.00 LBP )
Cost/Month: 32380,8 QAR ( 795,188,040.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 1079,3571 QAR ( 26,498,082.00 LBP )
Cost/Day: 1079,36 QAR ( 26,498,082.00 LBP )
Cost/Month: 32380,8 QAR ( 795,188,040.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 113,6439 OMR ( 26,072,942.00 LBP )
Cost/Day: 113,64 OMR ( 26,072,942.00 LBP )
Cost/Month: 3409,2 OMR ( 786,572,206.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 113,6439 OMR ( 26,072,942.00 LBP )
Cost/Day: 113,64 OMR ( 26,072,942.00 LBP )
Cost/Month: 3409,2 OMR ( 786,572,206.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 1008,5893 AED ( 24,354,288.00 LBP )
Cost/Day: 1008,59 AED ( 24,354,288.00 LBP )
Cost/Month: 30257,7 AED ( 731,039,377.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 1008,5893 AED ( 24,354,288.00 LBP )
Cost/Day: 1008,59 AED ( 24,354,288.00 LBP )
Cost/Month: 30257,7 AED ( 731,039,377.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 161,2268 CHF ( 16,650,620.00 LBP )
Cost/Day: 161,23 CHF ( 16,650,620.00 LBP )
Cost/Month: 4836,9 CHF ( 500,139,120.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 161,2268 CHF ( 16,650,620.00 LBP )
Cost/Day: 161,23 CHF ( 16,650,620.00 LBP )
Cost/Month: 4836,9 CHF ( 500,139,120.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 145,7907 GBP ( 16,479,105.00 LBP )
Cost/Day: 145,79 GBP ( 16,479,105.00 LBP )
Cost/Month: 4373,7 GBP ( 496,987,077.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 145,7907 GBP ( 16,479,105.00 LBP )
Cost/Day: 145,79 GBP ( 16,479,105.00 LBP )
Cost/Month: 4373,7 GBP ( 496,987,077.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 1218,6393 DKK ( 15,804,768.00 LBP )
Cost/Day: 1218,64 DKK ( 15,804,768.00 LBP )
Cost/Month: 36559,2 DKK ( 474,389,584.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 1218,6393 DKK ( 15,804,768.00 LBP )
Cost/Day: 1218,64 DKK ( 15,804,768.00 LBP )
Cost/Month: 36559,2 DKK ( 474,389,584.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 628,7979 SAR ( 14,845,920.00 LBP )
Cost/Day: 628,8 SAR ( 14,845,920.00 LBP )
Cost/Month: 18864 SAR ( 445,944,960.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 628,7979 SAR ( 14,845,920.00 LBP )
Cost/Day: 628,8 SAR ( 14,845,920.00 LBP )
Cost/Month: 18864 SAR ( 445,944,960.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 140,39 EUR ( 13,562,640.00 LBP )
Cost/Day: 140,39 EUR ( 13,562,640.00 LBP )
Cost/Month: 4211,7 EUR ( 407,944,836.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 140,39 EUR ( 13,562,640.00 LBP )
Cost/Day: 140,39 EUR ( 13,562,640.00 LBP )
Cost/Month: 4211,7 EUR ( 407,944,836.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 125,5521 EUR ( 12,109,500.00 LBP )
Cost/Day: 125,55 EUR ( 12,109,500.00 LBP )
Cost/Month: 3766,5 EUR ( 364,835,016.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 125,5521 EUR ( 12,109,500.00 LBP )
Cost/Day: 125,55 EUR ( 12,109,500.00 LBP )
Cost/Month: 3766,5 EUR ( 364,835,016.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
Cost/Unit: 210417,43 LBP ( 210,417.00 LBP )
Cost/Day: 210417,43 LBP ( 210,417.00 LBP )
Cost/Month: 6312522,9 LBP ( 6,312,522.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
Cost/Unit: 210417,43 LBP ( 210,417.00 LBP )
Cost/Day: 210417,43 LBP ( 210,417.00 LBP )
Cost/Month: 6312522,9 LBP ( 6,312,522.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info